Addmaster

Addmaster and Czebe-Med Continue to Collaborate for Growth

Addmaster and Czebe-Med Continue to Collaborate for Growth

Addmaster is proud to continue its successful partnership with Czebe-Med, its trusted distribution partner in Hungary. Together, the two companies have played a key role in expanding the reach of innovative additive technologies across Central Europe—ensuring customers benefit from high-quality, high-performance solutions that enhance both product functionality and brand reputation.

Czebe-Med has been instrumental in the distribution of Addmaster’s market-leading Biomaster antimicrobial additive, along with a range of complementary technologies tailored to meet the specific needs of sectors such as healthcare, packaging, textiles, and consumer goods.

The longstanding partnership between Addmaster and Czebe-Med is built on a foundation of shared values: a commitment to quality, transparent communication, and delivering measurable value to customers. This collaborative approach has helped drive consistent growth, strong customer relationships, and successful project outcomes across Hungary and beyond.

Kathleen Mason, Order Coordinator at Addmaster, comments on the positive working relationship: “Working with Gábor is always a pleasure – our working relationship is characterised by our mutual respect and co-operation. The collaboration is seamless and efficient.

With Czebe-Med’s deep understanding of the Hungarian market and Addmaster’s technical expertise, regulatory know-how, and supply chain support, the partnership is well-positioned to continue growing. Both companies remain focused on supporting customers with proven, science-backed solutions that improve hygiene, safety, and product performance.

 


 

What Next?

🔗 Follow us on Social Media, here is our LINK TREE

✉️ See how our additive technology can benefit your business by CONTACTING US

🦠 Find out more about Biomaster Antimicrobial Technology HERE

🎥 Watch our video on how Biomaster works WATCH NOW

📰 Subscribe to our Newsletter - SUBSCRIBE

← Back to news